|Articles|July 12, 2022

Clariness Extends Contract With Klinische Forschung Berlin GbR

More studies added to Clariness' patient recruitment platform.

Clariness has extended its contract with Klinische Forschung Berlin GbR (Klifo Berlin GbR) through listing additional studies on its platform.

Klifo Berlin GbR listed several studies on Clariness’ patient-friendly study platform, ClinLife, in March 2021. Since then, more than 75 patients have been enrolled and randomized.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

Clariness Extends Contract With Klinische Forschung Berlin GbR

Newsletter

Related Content

Imfinzi Plus FLOT Significantly Improves Overall Survival in Gastric and Gastroesophageal Cancer

Adaptive Trial Design as a Pathway to Faster Development

After the Trial is too Late: The Case for More Active Use of Patient-Reported Outcomes in Oncology Studies

Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor

Setting the Limits of Autonomy with Autonomous Agents for Clinical Research

Trending on Applied Clinical Trials Online

Imfinzi Plus FLOT Significantly Improves Overall Survival in Gastric and Gastroesophageal Cancer

Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor

Applied Clinical Trials: October 2025 Interactive Digital Edition

In With the New

Adaptive Trial Design as a Pathway to Faster Development